California Senate Votes to Decriminalize Psychedelics
California lawmakers have passed Senate Bill 58, a groundbreaking piece of legislation that decriminalizes the possession and personal use of
Read more
Psychedelics
FDA Releases Guidance for Psychedelic Drug Trials With Possibility of Removing Schedule I Classification
The U.S. Food and Drug Administration (FDA) has released a groundbreaking draft guidance to provide crucial insights for researchers exploring
Read more
Mind Cure Announces new CTO, Geoff Belair
This morning Mind Cure Health Inc. (CSE: MCUR) announced the hiring of Geoff Belair as their new Chief Technology Officer. Belair was the senior
Read more
Market Movers: Champignon Brands Tags $2; Up Over 35%
This morning Champignon Brands (CSE: SHRM) continued to gain momentum as the stock increased to $2, rising over 35% from
Read more
Champignon Brands Appoints Medipharm Labs CEO Pat McCutcheon to Board
This morning Champignon Brands Inc. (CSE: SHRM) announced the appointment of Pat McCutcheon to its board of directors effective immediately.
Read more
Shoom Street to Be Acquired By Graph Blockchain
Psychedelics are going main stream. This morning, Graph Blockchain (CSE: GBLC) announced that it signed a letter of intent to
Read more
Yield Growth Corp Continues Push Towards Psychedelic Mushroom Investment Narrative
The Yield Growth Corp (CSE: BOSS) is continuing to push its recently announced psilocybin mushroom narrative. The firm announced today
Read more
Roadman Investments To Establish Psychedelic Conference for Investors
Roadman Investments (TSXV: LITT), a firm focused on the production of mushrooms, announced this morning that it has formed a
Read more